Evidence map›Paper›PMID 27528276›Full record

ArticleInfection and immunity2016

Lipopolysaccharide Domains Modulate Urovirulence.

Lizath M Aguiniga, Ryan E Yaggie, Anthony J Schaeffer, David J Klumpp

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 43 citations in OpenAlex.

  1. Microbiology (Reading, England) · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Genomic characterization ofFrontiers in cellular and infection microbiology · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Peptidoglycan Endopeptidase Spr of UropathogenicFrontiers in microbiology · 2020
    Article
  19. UroPathogenicFrontiers in microbiology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lizath M AguinigaDepartment of Urology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Ryan E YaggieDepartment of Urology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Anthony J SchaefferDepartment of Urology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
David J KlumppDepartment of Urology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA d-klumpp@northwestern.edu.
Northwestern University · US

Funding

Mentoring For Success: Developing Fundamental Skills For Biomedical ResearchR25GM079300 · NIGMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MCGEE, RICHARD · 2007 to 2020
$6.6M
UTI Immune Modulation by LPS StructureF31AI106357 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI AGUINIGA, LIZATH MONSERRATH · 2013 to 2017
$163k
NIAID NIH HHS F31 AI106357NIGMS NIH HHS R25 GM079300
6 · The paper itself

Abstract

Uropathogenic Escherichia coli (UPEC) accounts for 80 to 90% of urinary tract infections (UTI), and the increasing rate of antibiotic resistance among UPEC isolates reinforces the need for vaccines to prevent UTIs and recurrent infections. Previous studies have shown that UPEC isolate NU14 suppresses proinflammatory NF-κB-dependent cytokines (D. J. Klumpp, A. C. Weiser, S. Sengupta, S. G. Forrestal, R. A. Batler, and A. J. Schaeffer, Infect Immun 69:6689-6695, 2001, http://dx.doi.org/10.1128/IAI.69.11.6689-6695.2001; B. K. Billips, A. J. Schaeffer, and D. J. Klumpp, Infect Immun 76:3891-3900, 2008, http://dx.doi.org/10.1128/IAI.00069-08). However, modification of lipopolysaccharide (LPS) structure by deleting the O-antigen ligase gene (waaL) enhanced proinflammatory cytokine secretion. Vaccination with the ΔwaaL mutant diminished NU14 reservoirs and protected against subsequent infections. Therefore, we hypothesized that LPS structural determinants shape immune responses. We evaluated the contribution of LPS domains to urovirulence corresponding to the inner core (waaP, waaY, and rfaQ), outer core (rfaG), and O-antigen (waaL, wzzE, and wzyE). Deletion of waaP, waaY, and rfaG attenuated adherence to urothelial cells in vitro In a murine UTI model, the ΔrfaG mutant had the most severe defect in colonization. The mutation of rfaG, waaL, wzzE, and wzyE resulted in an inability to form reservoirs in mouse bladders. Infection with the LPS mutant panel resulted in various levels of urinary myeloperoxidase. Since the ΔwaaL mutant promoted Th

Indexed as

Escherichia coli InfectionsAdaptive ImmunityAnimalsDisease Models, AnimalFemaleImmunity, InnateLipopolysaccharidesMiceMice, Inbred C57BLNeutrophilsO AntigensPeroxidaseUrinary Tract InfectionsUropathogenic Escherichia coliVirulenceLipopolysaccharidesO AntigensPeroxidase

Identifiers

PMID27528276
PMCPMC5067746
OpenAlexW2517705459

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.